mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |